Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Hypha Labs (FUNI) Notes Payables (2019 - 2025)

Hypha Labs (FUNI) has disclosed Notes Payables for 8 consecutive years, with $1.2 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Notes Payables rose 12.06% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Jun 2025, up 12.06%, and an annual FY2024 reading of $1.1 million, up 90.84% over the prior year.
  • Notes Payables was $1.2 million for Q2 2025 at Hypha Labs, up from $65600.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $1.7 million in Q2 2022 and bottomed at $20000.0 in Q4 2024.
  • Average Notes Payables over 5 years is $782894.9, with a median of $665000.0 recorded in 2022.
  • The sharpest move saw Notes Payables surged 2212.2% in 2021, then plummeted 98.58% in 2024.
  • Year by year, Notes Payables stood at $1.3 million in 2021, then plummeted by 88.23% to $150000.0 in 2022, then surged by 838.63% to $1.4 million in 2023, then tumbled by 98.58% to $20000.0 in 2024, then surged by 5941.18% to $1.2 million in 2025.
  • Business Quant data shows Notes Payables for FUNI at $1.2 million in Q2 2025, $65600.0 in Q1 2025, and $20000.0 in Q4 2024.